This article is 396 words and a three-minute read.
The BIH – Berlin Institute of Health @Charité has published a press release on the launch of the EU-CiP project. You can read the original here.
Development of the European Cancer Information Portal Launched
The Berlin Institute of Health at Charité (BIH) is coordinating the central European research project “EU-CiP” (European Cancer Information Portal). This project is funded with 12 million euros over four years by the European Union’s Horizon Europe programme.
For the first time, it establishes a European network of patient-centered, trustworthy, and evidence-based cancer information portals. EU-CiP is a key component of the European Cancer Patient Digital Centre (ECPDC), developed under the Europe’s Beating Cancer Plan and the EU Mission on Cancer.
EU-CiP’s objective is to enhance health literacy, empower patients, and promote equality in access to cancer care information across Europe. Under the scientific leadership and coordination of Prof. Dr. Roland Eils, Founding Director of the BIH Centre of Digital Health, EU-CiP unites 40 partner institutions from 18 countries. This includes patient organisations, clinical and scientific institutions, technology partners, and health literacy experts.
“With EU-CIP, we are creating a pan-European digital knowledge infrastructure that places the needs of patients at its core. Our goal is to improve access to trustworthy information about cancer diagnosis, treatment, and aftercare for all people in Europe, regardless of language, background, or level of education,” says Prof. Eils.
EU-CiP builds a shared library of evidence-based content accessible to all member states, featuring continuously reviewed and updated information by patient organisations in cooperation with medical societies and AI experts.
The German Cancer Information Service at the German Cancer Research Center (DKFZ) in Heidelberg is involved nationwide as an important development partner for content and infrastructure.
Participatory development and implementation
Initially, national and regional portals will be established in 11 member states, equipped with innovative services like a multilingual AI chatbot for personalised information. The platform also provides tools for content creation, presentation, and communication, with gradual integration into existing electronic health infrastructures. Particular focus is placed on high-incidence cancers, paediatric cancers, and tumours with poor prognosis.
Development and implementation are carried out in a participatory manner, involving patient representatives, patients, citizens, healthcare professionals, medical journalists, and infrastructure experts.
The initiative is aligned with the European Cancer Plan and the EU Cancer Mission, with EU funding underscoring its strategic importance for the digital transformation of cancer care in Europe.
ENDS
